pargyline has been researched along with Uremia in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siassi, F | 1 |
| Wang, M | 1 |
| Kopple, JD | 1 |
| Swendseid, ME | 1 |
1 other study available for pargyline and Uremia
| Article | Year |
|---|---|
Brain serotonin turnover in chronically uremic rats.
Topics: Animals; Brain; Female; Pargyline; Rats; Serotonin; Tryptophan; Uremia | 1977 |